NXC-201

· Hadassah Medical Organization

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NXC-201, covering 2025-03-14 to 2025-03-14. Get the full timeline:

Most recent: Clinical Trial Update: NXC-201 (formerly HBI0101) Multiple Myeloma [Phase 1]